Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fragment Hopping-Based Design of Novel Biphenyl-DAPY Derivatives as Potent Non-Nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Improved Anti-Resistance Efficacy
Ya-Li Sang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 7, pp. 4755-4767
Closed Access | Times Cited: 10

Showing 10 citing articles:

Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance
Kun Zhang, Yujie Zhang, Min Li, et al.
Medicinal Research Reviews (2024)
Closed Access | Times Cited: 5
Fragment Addition-Based Design of Heteroaromatic-Biphenyl-DAPYs as Potent and Orally Available Non-nucleoside Reverse Transcriptase Inhibitors Featuring Significantly Enhanced Safety
Wenjuan Huang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2024)
Closed Access | Times Cited: 3
From Lab to Clinic: The Discovery and Optimization Journey of PI3K Inhibitors
Siyu Lian, Zhenhua Du, Qingqing Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116786-116786
Closed Access | Times Cited: 2
Expanding the Solvent/Protein Region Occupation of the Non-Nucleoside Reverse Transcriptase Inhibitor Binding Pocket for Improved Broad-Spectrum Anti-HIV-1 Efficacy: from Rigid Phenyl-Diarylpyrimidines to Flexible Hydrophilic Piperidine-Diarylpyrimidines
Wenjuan Huang, Christophe Pannecouque, Erik De Clercq, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 21, pp. 19889-19904
Closed Access | Times Cited: 2
Discovery of Novel Fused-heterocycle-bearing Diarypyrimidine Derivatives as HIV-1 Potent NNRTIs Targeting Tolerant Region I for Enhanced Antiviral Activity and Resistance Profile
Jiaojiao Dai, Xiangyi Jiang, Heng Gao, et al.
European Journal of Medicinal Chemistry (2024) Vol. 281, pp. 117033-117033
Closed Access | Times Cited: 2
The latest developments in the design and discovery of non-nucleoside reverse transcriptase inhibitors (NNRTIs) for the treatment of HIV
Junyi Li, Bing Ye, Shenghua Gao, et al.
Expert Opinion on Drug Discovery (2024), pp. 1-18
Closed Access | Times Cited: 1
Advances in diarylpyrimidines and related analogues as HIV-1 nonnucleoside reverse transcriptase inhibitors (2019-2023)
M. Nie, Shuang‐Shuang Zhang, Shuang‐Xi Gu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 280, pp. 116973-116973
Closed Access | Times Cited: 1
Development of novel HEPT analogs featuring significantly improved anti-resistance potency against HIV-1 through chemical space exploration of the tolerant region I
Ruo-Lan Zhou, Christophe Pannecouque, Erik De Clercq, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106783-106783
Closed Access | Times Cited: 2
Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges
Anshul Mishra, Amandeep Thakur, Ram Lal Sharma, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 11, pp. 1355-1381
Closed Access
Nonlinear Controller Synthesis for HIV Dynamics Based on SOS
Yi Ding, Yong Zhang, Wei Liu, et al.
IEEE Access (2023) Vol. 12, pp. 43552-43559
Open Access
Page 1

Scroll to top